Genfit SA is a biopharmaceutical company involved in drug discovery and development for the early diagnosis, prevention and treatment of cardiometabolic diseases. The company is headquartered in Loos, Hauts-De-France and currently employs 180 full-time employees. The company went IPO on 2006-12-19. The firm provides therapeutic and diagnostic solutions for rare and serious liver diseases , with a particular interest in diseases with largely unmet medical needs. Its laboratory capabilities include pharmacology, molecular and cellular biology, drug candidate screening, medicinal and analytical chemistry, biochemistry, omics analyses, and data science. Its in-house biobank allows to have unparalleled control and precision in the handling and preservation of biological samples, which is crucial to research. The firm leverage artificial intelligence (image processing tools and language models) to create tools that accelerate daily work and decision-making.
Follow-Up Questions
Quelle est la performance du prix de l'action GNFT ?
Le prix actuel de GNFT est de $3.84, il a decreased de 5.18% lors de la dernière journée de trading.
Quels sont les thèmes d'affaires principaux ou les industries de Genfit SA ?
Genfit SA appartient à l'industrie Biotechnology et le secteur est Health Care
Quel est la capitalisation boursière de Genfit SA ?
La capitalisation boursière actuelle de Genfit SA est de $192.0M
Est-ce que Genfit SA est un achat, une vente ou un maintien ?
Selon les analystes de Wall Street, 8 analystes ont établi des notations d'analystes pour Genfit SA, y compris 8 achat fort, 4 achat, 1 maintien, 0 vente et 8 vente forte
